Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean G Tang

Showing results (21-30 of 133) with videos related to

Pageof 14
Sort By:
Seminars in Cancer Biology|May 13, 2018
Cancer stem cells: Regulation programs, immunological properties and immunotherapyDingxiao Zhang, Dean G Tang, Kiera Rycaj
Cancer Heterogeneity and Plasticity|October 4, 2024
Treatment-induced stemness and lineage plasticity in driving prostate cancer therapy resistanceAnmbreen Jamroze, Xiaozhuo Liu, Dean G Tang
The Journal of Biological Chemistry|October 31, 2002
Early mitochondrial activation and cytochrome c up-regulation during apoptosisDhyan Chandra, Jun-Wei Liu, Dean G Tang
Pathology Oncology Research : POR|January 1, 1996
Tyrosine Phosphorylation of a ~30 kD Protein Precedes avb3 Integrin-signaled Endothelial Cell Spreading and Motility on Matrix ProteinsDean G Tang, Clement A Diglio, Kenneth V Honn
Cell Cycle (Georgetown, Tex.)|February 2, 2013
New insights into prostate cancer stem cellsXin Chen, Kiera Rycaj, Xin Liu, et al.
Seminars in Cancer Biology|August 5, 2015
Cancer stem cells and cell size: A causal link?Qiuhui Li, Kiera Rycaj, Xin Chen, et al.
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|November 4, 2005
Cell survival signaling during apoptosis: implications in drug resistance and anti-cancer therapeutic developmentGrace Choy, Jun-Wei Liu, Dhyan Chandra, et al.
Advances in Experimental Medicine and Biology|October 3, 2019
Tumor Dormancy and Slow-Cycling Cancer CellsJohn E Davis, Jason Kirk, Yibing Ji, et al.
Prostaglandins & Other Lipid Mediators|December 14, 2006
15-lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size)Dean G Tang, Bobby Bhatia, Shaohua Tang, et al.
Stem Cells (Dayton, Ohio)|May 31, 2018
Concise Review: Prostate Cancer Stem Cells: Current UnderstandingSergej Skvortsov, Ira-Ida Skvortsova, Dean G Tang, et al.
Pageof 14

Showing results (21-30 of 133) with videos related to

Sort By:
Pageof 14
Seminars in Cancer Biology|May 13, 2018
Cancer stem cells: Regulation programs, immunological properties and immunotherapyDingxiao Zhang, Dean G Tang, Kiera Rycaj
Cancer Heterogeneity and Plasticity|October 4, 2024
Treatment-induced stemness and lineage plasticity in driving prostate cancer therapy resistanceAnmbreen Jamroze, Xiaozhuo Liu, Dean G Tang
The Journal of Biological Chemistry|October 31, 2002
Early mitochondrial activation and cytochrome c up-regulation during apoptosisDhyan Chandra, Jun-Wei Liu, Dean G Tang
Pathology Oncology Research : POR|January 1, 1996
Tyrosine Phosphorylation of a ~30 kD Protein Precedes avb3 Integrin-signaled Endothelial Cell Spreading and Motility on Matrix ProteinsDean G Tang, Clement A Diglio, Kenneth V Honn
Cell Cycle (Georgetown, Tex.)|February 2, 2013
New insights into prostate cancer stem cellsXin Chen, Kiera Rycaj, Xin Liu, et al.
Seminars in Cancer Biology|August 5, 2015
Cancer stem cells and cell size: A causal link?Qiuhui Li, Kiera Rycaj, Xin Chen, et al.
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|November 4, 2005
Cell survival signaling during apoptosis: implications in drug resistance and anti-cancer therapeutic developmentGrace Choy, Jun-Wei Liu, Dhyan Chandra, et al.
Advances in Experimental Medicine and Biology|October 3, 2019
Tumor Dormancy and Slow-Cycling Cancer CellsJohn E Davis, Jason Kirk, Yibing Ji, et al.
Prostaglandins & Other Lipid Mediators|December 14, 2006
15-lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size)Dean G Tang, Bobby Bhatia, Shaohua Tang, et al.
Stem Cells (Dayton, Ohio)|May 31, 2018
Concise Review: Prostate Cancer Stem Cells: Current UnderstandingSergej Skvortsov, Ira-Ida Skvortsova, Dean G Tang, et al.
Pageof 14